N/A
N=16,789
Chronic Migraine Epidemiology and Outcomes Study
Migraine Disorders
Bottom Line
View on ClinicalTrials.gov: NCT01648530 ↗Enrolled (actual)
16,789
Serious AEs
—
Results posted
Jan 2015
Primary outcome: Primary: Percentage of Participants With Episodic Migraine (EM) or Chronic Migraine (CM) — 91.2; 8.8 percentage of participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- No Treatment (Other)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Allergan
- Primary completion
- Nov 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With Episodic Migraine (EM) or Chronic Migraine (CM) |
91.2; 8.8 | — |
| PRIMARY Migraine Disability Assessment (MIDAS) |
13.1; 60.5 | — |
Summary
This is a population internet-based study to characterize migraine clinical course and impact on family.
Eligibility Criteria
Inclusion Criteria
- History of migraine
- U.S. Member of Survey Panel
- Household member of study participant
- Ability to complete internet-based questionnaires
Exclusion Criteria
- No access to internet
Data sourced from ClinicalTrials.gov (NCT01648530). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.